Know Cancer

or
forgot password

    • cancer clinical trials in morgantown, WV

    • Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Sarcoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Neuroblastoma
    Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Morgantown, West Virginia 26506
    Breast Cancer, Advanced Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    West Virginia University
    Morgantown, West Virginia 26506
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
    West Virginia University Hospital
    Morgantown, West Virginia 26506-9162
    Lymphoma
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Melanoma (Skin)
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    West Virginia University/ Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Multiple Myeloma
    Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Leukemia
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Lung Cancer
    Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
    West Virginia University
    Morgantown, West Virginia 26506
    Smokeless Tobacco Use, Tobacco Dependence
    Connect® MM- The Multiple Myeloma Disease Registry
    West Virginia University - Clinical Trials Research Unit
    Morgantown, West Virginia 26506
    Multiple Myeloma
    Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
    West Virginia University
    Morgantown, West Virginia 26506
    Hematopoietic/Lymphoid Cancer, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    West Virginia University
    Morgantown, West Virginia 26506
    Breast Cancer
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    West Virginia University Hospital
    Morgantown, West Virginia 26506-9162
    Chronic GVHD
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Lung Cancer
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    West Virginia University Hospital
    Morgantown, West Virginia 26506-9162
    Multiple Myeloma
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    West Virginia University
    Morgantown, West Virginia 26506
    Peripheral T-cell Lymphoma
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10045 Boehringer Ingelheim Investigational Site
    Morgantown, West Virginia
    Breast Neoplasms
    Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Lymphoma
    Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Kidney Cancer
    Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Graft vs Host Disease
    Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Department of Medicine Section of Hematology/Oncology, West Virginia University Hospitals, Mary Babb Randolph Cancer Center, West Virginia University
    Morgantown, West Virginia 26506
    Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Morgantown, West Virginia 26506
    Rheumatoid Arthritis
    Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    West Virginia University
    Morgantown, West Virginia 26506
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    West Virginia University
    Morgantown, West Virginia 26506
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    West Virginia University Mary Baab Randolph Cancer Center
    Morgantown, West Virginia 26506
    Advanced Prostate Cancer, Prostatic Neoplasms
    Study of Oral MLN9708 in Combination With Melphalan and Prednisone in Patients With Newly Diagnosed Multiple Myeloma
    Mary Babb Randolph Cancer Center/WVU
    Morgantown, West Virginia 26506
    Multiple Myeloma
    Reduced Intensity Conditioning Versus Myeloablative Conditioning for Acute Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
    West Virginia University Hospital
    Morgantown, West Virginia 26506-9162
    Leukemia, Myelocytic, Acute
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    West Virginia University
    Morgantown, West Virginia 26506
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Lymphoma
    A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
    Investigational Site Number 840002
    Morgantown, West Virginia 26506
    Lymphoma
    Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Lymphoma, Neurotoxicity, Therapy-related Toxicity
    Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
    West Virginia University Hospitals
    Morgantown, West Virginia 26506-9300
    Breast Cancer
    Safety and Tolerability Study of SNS01-T in Relapsed or Refractory Multiple Myeloma, Mantle Cell Lymphoma, or Diffuse Large B Cell Lymphoma
    West Virginia University Mary Babb Randolf Cancer Center
    Morgantown, West Virginia 26506
    Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Mantle Cell Lymphoma in Relapse, Diffuse Large B Cell Lymphoma in Relapse
    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
    Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    Effect of Diet and Exercise in Breast Cancer Survivors
    West Virginia University
    Morgantown, West Virginia 26506
    Breast Cancer, Obesity
    Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Neurotoxicity
    Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Mucositis
    Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
    West Virginia University
    Morgantown, West Virginia 26506
    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
    West Virginia University-Mbrcc
    Morgantown, West Virginia 26506-9162
    Squamous Cell Non-small Cell Lung Cancer
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    West Virginia University, Site #154
    Morgantown, West Virginia 26506
    Chronic Myeloid Leukemia
    Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Graft vs Host Disease
    Home Telemonitoring for Patients With Lung Cancer
    WVU Mary Babb Randolph Cancer Center and Ruby Hospital
    Morgantown, West Virginia 26506
    Lung Cancer
    1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Rash
    A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
    West Virginia University
    Morgantown, West Virginia 26506
    For Donors:, Related Donors Donating PBSC to a Family Member, For Recipients:, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia
    Prospective Study of Lymphoproliferative Diseases
    West Virginia University Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma
    Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
    Mary Babb Randolph Cancer Center at West Virginia University Hospitals
    Morgantown, West Virginia 26506
    Breast Cancer, HER2-negative Breast Cancer
    Belimumab Assessment of Safety in SLE
    GSK Investigational Site
    Morgantown, West Virginia 26506
    Systemic Lupus Erythematosus
    Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma
    West Virginia University
    Morgantown, West Virginia 26506
    Hodgkin Lymphoma
    Effect of Body Mass on Acyclovir Pharmacokinetics
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Hematological Malignancy, Pharmacokinetics of Acyclovir
    Effect of Body Mass on Filgrastim Pharmacokinetics
    West Virginia University Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Hematological Malignancy, Pharmacokinetics of Filgrastim
    FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer
    West Virginia University Healthcare
    Morgantown, West Virginia 26506
    Colorectal Cancer Metastatic
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    West Virginia University/ Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    CML
    A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
    WVU Healthcare
    Morgantown, West Virginia 26506
    Chemotherapy-Induced Nausea and Vomiting
    Cord Blood Transplant
    West Virginia University Hospitals Mary Babb Randolph Cancer Center
    Morgantown, West Virginia 26506
    Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Severe Aplastic Anemia